Linspec 50/100 mg/ml Solution for injection for dogs, cats, pigs and pre-ruminant calves

国: アイルランド

言語: 英語

ソース: HPRA (Health Products Regulatory Authority)

有効成分:

Lincomycin hydrochloride; Spectinomycin sulfate tetrahydrate

から入手可能:

Chanelle Pharmaceuticals Manufacturing Limited

ATCコード:

QJ01FF52

INN（国際名）:

Lincomycin hydrochloride; Spectinomycin sulfate tetrahydrate

投薬量:

50, 100 milligram(s)/millilitre

医薬品形態:

Solution for injection

処方タイプ:

POM: Prescription Only Medicine as defined in relevant national legislation

治療群:

Cats, Cattle, Dogs, Pigs

治療領域:

lincomycin, combinations

適応症:

Antibacterial

認証ステータス:

Authorised

承認日:

2010-07-29

製品の特徴

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Linspec 50/100 mg/ml Solution for injection for dogs, cats, pigs and
pre-ruminant calves
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Solution for injection.
Clear colourless solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle (pre-ruminating calves), Pigs, dogs and cats.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of respiratory infections, intestinal infections, urinary
tract infections, skin infections (including wounds and
abscess) and arthritis caused by organisms sensitive to lincomycin and
/ or spectinomycin including:
_Actinobacillus_ spp.
_Pasteurella_ spp.
_Brachyspira hyodysenteriae_
_Escherichia coli_
_Salmonella_ spp.
_Campylobacter_ spp.
_Bacteroides_ spp.
_Clostridium_ spp.
_Fusobacterium_ spp.
_Actinomyces_ spp.
_Staphylococcus_ spp.
_Streptococcus_ spp.
_Mycoplasma_ spp.
4.3 CONTRAINDICATIONS
Do not use in case of known hypersensitivity to the active substances
or to any of the excipients.
Do not
administer to rabbits,
hamsters,
guinea pigs,
chinchillas,
horses or ruminants as this could result
in severe
gastro-intestinal disturbance.
Each ml contains:
ACTIVE SUBSTANCE
Lincomycin (as lincomycin hydrochloride)
50
mg
Spectinomycin (as spectinomycin sulfate tetrahydrate) 100 mg
EXCIPIENTS
Benzyl alcohol (E1519)
9
mg
For the full list of excipients, see section 6.1.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_5_
_/_
_0_
_9_
_/_
_2_
_0_